M. Wouter Dercksen
Radboud University Nijmegen(NL)Máxima Medisch Centrum(NL)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis(2007)322 cited
- → Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome(2013)248 cited
- → The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets(2021)118 cited
- → In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium(2015)80 cited
- → Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia(2013)49 cited
- → Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia(2013)42 cited